Revolutions Medical CORP Research and Development Expense
Revolutions Medical CORP reported Research and Development Expense of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-05-20
- Revolutions Medical CORP research and development expense for the quarter ending 2014-03-31 was $0.00.
- Revolutions Medical CORP research and development expense for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- Revolutions Medical CORP research and development expense for the quarter ending 2012-12-31 was -$64.04K.
- Revolutions Medical CORP research and development expense for the quarter ending 2012-09-30 was $9.90K.
- Revolutions Medical CORP research and development expense for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Revolutions Medical CORP research and development expense for fiscal 2012 was $35.54K, a 37.64% decline from fiscal 2011.
- Revolutions Medical CORP research and development expense for fiscal 2011 was $57.00K, a 77.85% decline from fiscal 2010.
- Revolutions Medical CORP research and development expense for fiscal 2010 was $257.35K, a 15.07% decline from fiscal 2009.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 172 month | Research and Development Expense 175 month | Research and Development Expense 178 month | Research and Development Expense 181 month | Research and Development Expense 184 month | Research and Development Expense 187 month | Research and Development Expense 190 month | Research and Development Expense 193 month | Research and Development Expense 196 month | Research and Development Expense 199 month | Research and Development Expense 202 month | Research and Development Expense 205 month | Research and Development Expense 208 month | Research and Development Expense 211 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-20 | $2.94M 10-Q · filed 2014-05-20 | |||||||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2014-04-14 | $2.94M 10-K · filed 2014-04-14 | |||||||||||||||||
| 2013-09-30 | $2.94M 10-Q · filed 2013-11-19 | ||||||||||||||||||
| 2013-06-30 | $2.94M 10-Q/A · filed 2013-08-22 | ||||||||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-20 | -$64.04K derived: sum of 2 quarters · filed 2014-05-20 | -$54.14K derived: sum of 3 quarters · filed 2014-05-20 | -$35.84K derived: sum of 4 quarters · filed 2014-05-20 | $2.94M 10-Q · filed 2013-05-21 | ||||||||||||||
| 2012-12-31 | -$64.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-14 | -$54.14K derived: sum of 2 quarters · filed 2014-04-14 | -$35.84K derived: sum of 3 quarters · filed 2014-04-14 | $35.54K 10-K · filed 2014-04-14 | $2.94M 10-K · filed 2013-05-02 | ||||||||||||||
| 2012-09-30 | $9.90K 10-Q · filed 2013-11-19 | $28.20K derived: sum of 2 quarters · filed 2013-11-19 | $99.59K 10-Q · filed 2013-11-19 | $44.76K derived: sum of 4 quarters · filed 2013-11-19 | $3.05M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $18.30K 10-Q/A · filed 2013-08-22 | $89.69K 10-Q/A · filed 2013-08-22 | $34.86K derived: sum of 3 quarters · filed 2013-08-22 | $34.86K derived: sum of 4 quarters · filed 2013-08-22 | $3.04M 10-Q/A · filed 2012-09-13 | ||||||||||||||
| 2012-03-31 | $71.39K 10-Q · filed 2013-05-21 | $16.56K derived: sum of 2 quarters · filed 2013-05-21 | $16.56K derived: sum of 3 quarters · filed 2013-05-21 | $128.39K derived: sum of 4 quarters · filed 2013-05-21 | $3.03M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | -$54.83K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-02 | -$54.83K derived: sum of 2 quarters · filed 2013-05-02 | $57.00K derived: sum of 3 quarters · filed 2013-05-02 | $57.00K 10-K · filed 2013-05-02 | $111.83K 10-K · filed 2012-03-30 | $2.96M 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $111.83K derived: sum of 2 quarters · filed 2012-11-14 | $111.83K 10-Q · filed 2012-11-14 | $6.26M 10-Q · filed 2011-11-18 | |||||||||||||||
| 2011-06-30 | $111.83K 10-Q/A · filed 2012-09-13 | $111.83K 10-Q/A · filed 2012-09-13 | $6.26M 10-Q/A · filed 2011-10-21 | ||||||||||||||||
| 2011-03-31 | $2.84M 10-Q/A · filed 2011-09-16 | ||||||||||||||||||
| 2010-12-31 | $257.35K 10-K · filed 2012-03-30 | $2.84M 10-K/A · filed 2011-09-16 | |||||||||||||||||
| 2009-12-31 | $303.00K 10-K/A · filed 2011-09-16 |